STRINGER BRADLEY MICHAEL JOHN has a total of 24 patent applications. Its first patent ever was published in 1995. It filed its patents most often in WIPO (World Intellectual Property Organization), Czechia and United Kingdom. Its main competitors in its focus markets biotechnology, pharmaceuticals and medical technology are TOKYO WOMEN'S MEDICAL COLLEGE, METCELA INC and DAVIES JOHN E.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Czechia | 5 | |
#3 | United Kingdom | 4 | |
#4 | Canada | 3 | |
#5 | Australia | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Hungary | 1 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Medical technology | |
#4 | Agriculture | |
#5 | Measurement | |
#6 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Animal care | |
#6 | Object sterilising | |
#7 | Climate change adaptation technologies | |
#8 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Stringer Bradley Michael John | 24 |
Publication | Filing date | Title |
---|---|---|
GB9610809D0 | Method for controlling differentiation of precursor cells | |
HUT77472A | Targeted t lymphocytes | |
GB9522562D0 | Preparation of human cell-lines of fully-differentiated cells of specific tissue type | |
EP0789757A1 | Transgenic organisms and their uses | |
WO9614396A1 | Neural cultures | |
GB9521859D0 | Chondrocyte cell-lines | |
CZ182497A3 | Chondrocytic cellular lines |